These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16163240)

  • 1. Acute reversal of anticoagulant-induced bleeding complications.
    Crowther MA
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):578-82. PubMed ID: 16163240
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of bleeding in dialysis patients.
    Galbusera M; Remuzzi G; Boccardo P
    Semin Dial; 2009; 22(3):279-86. PubMed ID: 19573008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The antithrombotic-treated patient].
    Nielsen JD; Rasmussen HM; Husted SE
    Ugeskr Laeger; 2006 Dec; 168(49):4296-9. PubMed ID: 17164056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current challenges of anticoagulant treatment.
    Ginghină C; Giuşcă S; Serban M; Popescu BA; Jurcuţ R; Uscăţescu V
    Rom J Intern Med; 2007; 45(3):221-7. PubMed ID: 18333353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bleeding complications of anticoagulant therapy].
    Gumulec J; Kessler P; Procházka V; Brejcha M; Penka M; Zänger M; Machytka E; Klement P
    Vnitr Lek; 2009 Mar; 55(3):277-89. PubMed ID: 19378860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to the bleeding patient.
    Marengo-Rowe AJ
    Int Anesthesiol Clin; 1982; 20(4):137-56. PubMed ID: 6816739
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
    Baric D; Biocina B; Unic D; Sutlic Z; Rudez I; Vrca VB; Brkic K; Ivkovic M
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):366-71; discussion 371. PubMed ID: 17218108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversing anticoagulation in the hemorrhaging patient.
    Treml B; Oswald E; Schenk B
    Curr Opin Anaesthesiol; 2019 Apr; 32(2):206-212. PubMed ID: 30817397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials of new anticoagulants.
    Anderson J; O'Donnell M
    Vnitr Lek; 2006 Mar; 52 Suppl 1():123-6. PubMed ID: 16637460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in antidotes for direct oral anticoagulants: their arrival is imminent.
    Lauw MN; Coppens M; Eikelboom JW
    Can J Cardiol; 2014 Apr; 30(4):381-4. PubMed ID: 24680169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of fibrinolysis inhibitors on anticoagulant induced hemorrhages].
    Vogel G; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(4):367-75. PubMed ID: 4127132
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemorrhagic complications during warfarin treatment].
    Gumulec J; Kessler P; Penka M; Klodová D; Králová S; Brejcha M; Wróbel M; Sumná E; Blatný J; Klaricová K; Riedlová P; Lasota Z
    Vnitr Lek; 2006 Mar; 52 Suppl 1():79-91. PubMed ID: 16637455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Challenges of the antithrombotic treatment. The Danish Society for Thrombosis and Hemostasis].
    Münster AM; Kristensen SR;
    Ugeskr Laeger; 2008 Mar; 170(12):1055. PubMed ID: 18397673
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options.
    Rothman MT
    Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):465-74. PubMed ID: 16265587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Haemo-cholecyst as a complication of anticoagulant and anti-platelet treatment].
    Ángel JM; Bermúdez RP; Conde MA; Sampedro JE; Jofré JG
    Cir Esp; 2011 May; 89(5):327-9. PubMed ID: 21419396
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention and treatment of major blood loss.
    Szabo S; Oikonomopoulos T; Hoffmeister HM
    N Engl J Med; 2007 Sep; 357(12):1260; author reply 1261. PubMed ID: 17881761
    [No Abstract]   [Full Text] [Related]  

  • 19. The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT.
    Cimenti C; Koestenberger M; Leschnik B; Haidl H; Muntean W
    Thromb Res; 2007; 119(3):361-7. PubMed ID: 16712904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Routine use of fibrinolysis inhibitors in obstetrics?].
    Loch EG
    Med Klin; 1967 Jan; 62(2):57-9. PubMed ID: 5301899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.